Truist lowered the firm’s price target on Inspire Medical (INSP) to $235 from $250 and keeps a Buy rating on the shares. The company’s Q4 ...

Morgan Stanley lowered the firm’s price target on Inspire Medical (INSP) to $220 from $230 and keeps an Overweight rating on the shares. Though ...

Katie Price has been spotted partying in a nightclub just days after she underwent multiple cosmetic procedures in Turkey - ...

RBC Capital Markets upheld a positive outlook on Inspire Medical Systems (NYSE:INSP) shares, reiterating an Outperform rating with a steady price target of $260.00. The stock currently trades at $180.

Microbot Medical Inc. (Nasdaq: MBOT) today announced the closing of its previously announced registered direct offering ...

Chinese company says DeepSeek’s AI model will enhance data mining in its platform, delivering efficiency to hospitals and ...

The gross proceeds to the Company from the offerings are expected to be approximately $13 million, before deducting the ...

The improved performance came in the period premiums from medical insurance rose 22.8 percent to Sh46.3 billion.

If enacted in 2022, the Fair Pricing Act could have saved patients up to $213.4 million in out-of-pocket costs, research says.

Morgan Stanley (NYSE:MS) adjusted its outlook on Inspire Medical Systems (NYSE:INSP), reducing the price target from $230.00 to $220.00, yet continuing to endorse the stock with an Overweight rating.

Globus Medical (NYSE: GMED), a leading musculoskeletal solutions company, and Nevro Corp. (NYSE: NVRO), a global medical ...